MediLink Therapeutics Pipeline
| Drug | Indication | Phase |
|---|
| YL201 | Solid Tumors (SCLC, NPC) | Phase 3 |
| YL202 | Solid Tumors | Phase 1 |
| YL205 | Solid Tumors | Phase 1 |
| YL217 | Solid Tumors | Phase 1 |
| YL211 | Solid Tumors | Phase 1 |
| YL212 | Solid Tumors | Phase 1 |
| YL215 | Solid Tumors | Phase 1 |
| YL221 | Solid Tumors | Phase 1 |